D-Index & Metrics Best Publications

Roland M. du Bois

Imperial College London
United Kingdom

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name Citations Publications World Ranking National Ranking

Medicine D-index 83 Citations 34,758 192 World Ranking 10290 National Ranking 969

Best Publications

Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis

Luca Richeldi;Roland M. du Bois;Ganesh Raghu;Arata Azuma.
The New England Journal of Medicine (2014)

3462 Citations

Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials.

Paul W Noble;Carlo Albera;Williamson Z Bradford;Ulrich Costabel.
The Lancet (2011)

1930 Citations

Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis.

Luca Richeldi;Ulrich Costabel;Moises Selman;Dong Soon Kim.
The New England Journal of Medicine (2011)

1106 Citations

Induction of Epithelial-Mesenchymal Transition in Alveolar Epithelial Cells by Transforming Growth Factor-β1 : Potential Role in Idiopathic Pulmonary Fibrosis

Brigham C. Willis;Brigham C. Willis;Brigham C. Willis;Janice M. Liebler;Katherine Luby-Phelps;Andrew G. Nicholson.
American Journal of Pathology (2005)

1093 Citations

Interstitial lung disease in systemic sclerosis: a simple staging system.

Nicole S. L. Goh;Sujal R. Desai;Srihari Veeraraghavan;David M. Hansell.
American Journal of Respiratory and Critical Care Medicine (2008)

1038 Citations

A common MUC5B promoter polymorphism and pulmonary fibrosis

Max A. Seibold;Anastasia L. Wise;Marcy C. Speer;Mark P. Steele.
The New England Journal of Medicine (2011)

1015 Citations

BUILD-3: A Randomized, Controlled Trial of Bosentan in Idiopathic Pulmonary Fibrosis

Talmadge E. King;Jürgen Behr;Kevin K. Brown;Roland M. du Bois.
American Journal of Respiratory and Critical Care Medicine (2008)

955 Citations

A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma.

Rachel K Hoyles;Ross W Ellis;Jessica Wellsbury;Belinda Lees.
Arthritis & Rheumatism (2006)

871 Citations

Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome.

Demosthenes Bouros;Athol U Wells;Andrew G Nicholson;Andrew G Nicholson;Thomas V Colby.
American Journal of Respiratory and Critical Care Medicine (2002)

865 Citations

An Official American Thoracic Society Clinical Practice Guideline: The Clinical Utility of Bronchoalveolar Lavage Cellular Analysis in Interstitial Lung Disease

Keith C. Meyer;Ganesh Raghu;Robert P. Baughman;Kevin K. Brown.
American Journal of Respiratory and Critical Care Medicine (2012)

853 Citations

If you think any of the details on this page are incorrect, let us know.